Skip to main content

Cullinan Therapeutics, Inc.

CGEM
Exchange
Nasdaq
Industry
Biological Products, (No Diagnostic Substances)
SEC CIK
0001789972

In the last 90 days, Cullinan Therapeutics, Inc. insiders filed 0 open-market purchases and 2 sales; 183 institutions reported holding it in 13F filings for Q2 2026, worth $1.30B in total; no superinvestor holds it.

Q1 2026 vs. Q4 2025

How the institutions holding Cullinan Therapeutics, Inc. changed between Q4 2025 and Q1 2026.

All holders in Q1 2026All holders in Q4 2025

13F holders of CGEM: Q4 2025 compared with Q1 2026
MeasureQ4 2025Of which not filed for Q1 2026Q1 2026Change
Holders1532174+23
Shares63.2M3.30M65.6M+5.67M (+9.5%)
Value$653.8M$34.1M$931.0M+$311.3M (+50.2%)

2 institutions that held it in Q4 2025 haven't filed for Q1 2026 yet. Not filing isn't selling, so the changes leave them out.

New holders (40)

Institutions that held Cullinan Therapeutics, Inc. at the end of Q1 2026 but not at the end of Q4 2025.

Institutions new to CGEM in Q1 2026
InstitutionSharesValue% of portfolio
Vanguard Capital Management LLC2,483,034$35.3M0.00%
Vanguard Portfolio Management LLC552,553$7.85M0.00%
Soleus Capital Management, L.P.410,200$5.83M0.24%
TCG Crossover Management, LLC406,786$5.78M0.17%
Vanguard Fiduciary Trust Co342,852$4.87M0.00%
Longaeva Partners L.P.183,691$2.61M0.13%
Prudential Financial Inc149,445$2.12M0.00%
TD Asset Management Inc114,400$1.63M0.00%
Moore Capital Management, LP105,960$1.51M0.05%
Bleichroeder LP100,000$1.42M0.25%
Y-Intercept (Hong Kong) Ltd95,417$1.36M0.03%
Cinctive Capital Management LP94,444$1.34M0.09%
Toroso Investments, LLC62,421$887.0K0.00%
Apis Capital Advisors, LLC60,000$852.6K0.13%
Superstring Capital Management LP59,484$845.3K0.60%
Optimize Financial Inc28,158$400.1K0.20%
CI Private Wealth, LLC27,885$396.2K0.00%
Ieq Capital, LLC27,736$394.1K0.00%
Vanguard Global Advisers, LLC27,066$384.6K0.00%
Knott David M Jr24,200$343.9K0.20%
Vanguard Asset Management, Ltd20,045$284.8K0.00%
Mercer Global Advisors Inc14,109$200.5K0.00%
Verdad Advisers, LP12,604$179.1K0.20%
Quadrature Capital Ltd10,577$150.3K0.00%
State of New Jersey Common Pension Fund D10,095$143.4K0.00%
Leonteq Securities AG10,000$142.1K0.01%
Group One Trading, L.P.8,856$125.8K0.00%
Vanguard Investments Australia, Ltd.7,272$103.3K0.00%
Federation des caisses Desjardins du Quebec2,000$28.4K0.00%
Capital Advisors, Ltd. LLC1,600$23.0K0.00%
BNP PARIBAS ASSET MANAGEMENT Holding S.A.922$13.1K0.00%
Bangor Savings Bank842$12.0K0.00%
Rockefeller Capital Management L.P.649$9.22K0.00%
Federated Hermes, Inc.516$7.33K0.00%
Quantbot Technologies LP122$1.73K0.00%
Wealth Preservation Advisors, LLC84$1.19K0.00%
Fifth Third Bancorp63$8950.00%
Root Financial Partners, LLC62$8810.00%
True Wealth Design, LLC54$7680.00%
Basecamp Wealth Advisors LLC27$3840.00%

Sold out (17)

Institutions that held Cullinan Therapeutics, Inc. at the end of Q4 2025 and filed for Q1 2026 without it.

Not filed for Q1 2026 yet (2)

Institutions that held Cullinan Therapeutics, Inc. at the end of Q4 2025 and haven't filed a 13F for Q1 2026. Not filing isn't selling, so they aren't counted as sold out.

Institutions holding CGEM in Q4 2025 that haven't filed for Q1 2026
InstitutionShares, Q4 2025Value, Q4 2025
Vanguard Group Inc3,298,504$34.1M
Comerica Bank66$683